Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

3(60.0%)

Phase 1

1(20.0%)

Phase 4

1(20.0%)

5Total

Phase 2(3)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02987634Phase 4Unknown

Evaluation and Comparison of Efficacy of PeriActive Mouthwash to Chlorhexidine 0.12% Mouth Rinse

Role: lead

NCT02313545Phase 1Completed

Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV

Role: lead

NCT01400620Phase 2Completed

Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer

Role: lead

NCT01427569Phase 2Completed

Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers

Role: lead

NCT00731432Phase 2Suspended

Herbal Periodontal Patch (THPP) for Gingival Inflammation in Diabetics

Role: lead

All 5 trials loaded